182 related articles for article (PubMed ID: 35574548)
1. Impact of Medical Community Model on Intravenous Alteplase Door-to-Needle Times and Prognosis of Patients With Acute Ischemic Stroke.
Li H; Xu D; Xu Y; Wei L
Front Surg; 2022; 9():888015. PubMed ID: 35574548
[TBL] [Abstract][Full Text] [Related]
2. [Effect of prehospital intervention based on emergency medical services on door-to-needle time of thrombolysis in acute ischemic stroke].
Wang Y; Zhang C; Sun W; Hu X; Lyu Z; Liu W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Jul; 30(7):667-670. PubMed ID: 30045795
[TBL] [Abstract][Full Text] [Related]
3. An in-hospital stroke system to optimize emergency management of acute ischemic stroke by reducing door-to-needle time.
Zhang Y; Zhu Y; Jiang T; Liu J; Tang X; Yi W
Am J Emerg Med; 2023 Jul; 69():147-153. PubMed ID: 37119700
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy and safety of hypernormal shortened door to needle time (DNT) plus individualized low-dose alteplase therapy in treating acute ischemic stroke.
Zheng M; Lei H; Cui Y; Yang D; Wang L; Wang Z
Pak J Med Sci; 2016; 32(4):811-6. PubMed ID: 27648019
[TBL] [Abstract][Full Text] [Related]
5. Impact of homocysteine levels on clinical outcome in patients with acute ischemic stroke receiving intravenous thrombolysis therapy.
Li L; Ma X; Zeng L; Pandey S; Wan R; Shen R; Zhang Q
PeerJ; 2020; 8():e9474. PubMed ID: 32728492
[TBL] [Abstract][Full Text] [Related]
6. Impact of an emergency medicine pharmacist on door to needle alteplase time and patient outcomes in acute ischemic stroke.
Barbour J; Hushen P; Newman GC; Vidal J
Am J Emerg Med; 2022 Jan; 51():358-362. PubMed ID: 34823191
[TBL] [Abstract][Full Text] [Related]
7. Real-world data of tenecteplase vs. alteplase in the treatment of acute ischemic stroke: a single-center analysis.
Yao Y; Wu Y; Zhang X; Liu C; Cai L; Ying Y; Yang J
Front Neurol; 2024; 15():1386386. PubMed ID: 38708004
[TBL] [Abstract][Full Text] [Related]
8. Rt-PA thrombolytic therapy in patients with acute posterior circulation stroke: A retrospective study.
Hu Y; Zheng H; Chen X; Gao Z
Med Int (Lond); 2022; 2(2):8. PubMed ID: 36699100
[TBL] [Abstract][Full Text] [Related]
9. [Determinants of door to needle time for intravenous thrombolysis in acute ischemic stroke].
Brunser AM; Mazzon E; Muñoz P; Hoppe A; Lavados PM; Rojo A; Navia V; Cavada G; Olavarría VV; Mansilla E
Rev Med Chil; 2020 Aug; 148(8):1090-1095. PubMed ID: 33399775
[TBL] [Abstract][Full Text] [Related]
10. Outcome of acute ischaemic stroke patients after intravenous alteplase in Hospital Universiti Sains Malaysia.
Wong KY; Baharuddin KA; Masykurin MM; Abdul Halim S; Chee YC; Sapiai NA; Abdullah MS
Med J Malaysia; 2021 Nov; 76(6):870-875. PubMed ID: 34806675
[TBL] [Abstract][Full Text] [Related]
11. Short Door-to-Needle Times in Acute Ischemic Stroke and Prospective Identification of Its Delaying Factors.
Van Schaik SM; Scott S; de Lau LM; Van den Berg-Vos RM; Kruyt ND
Cerebrovasc Dis Extra; 2015; 5(2):75-83. PubMed ID: 26265910
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of intravenous thrombolytic therapy for acute ischemic stroke with an integrated acute stroke referral network: initial experience of a community-based hospital in a developing country.
Muengtaweepongsa S; Dharmasaroja P; Kummark U
J Stroke Cerebrovasc Dis; 2012 Jan; 21(1):42-6. PubMed ID: 22225863
[TBL] [Abstract][Full Text] [Related]
13. Interhospital transfer on intravenous thrombolysis in patients with acute ischemic stroke in three chinese municipal stroke centers.
Ding Y; Ji Z; Ma L; Zhai T; Gu Z; Niu J; Liu Y
J Thromb Thrombolysis; 2019 Nov; 48(4):580-586. PubMed ID: 31264060
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of the 30-minute door-to-needle time standard for alteplase administration.
Rajan SS; Decker-Palmer M; Wise J; Dao T; Salem C; Savitz SI
Ann Clin Transl Neurol; 2021 Aug; 8(8):1592-1600. PubMed ID: 34247448
[TBL] [Abstract][Full Text] [Related]
15. Utilization of Intravenous Tissue Plasminogen Activator and Reasons for Nonuse in Acute Ischemic Stroke in Saudi Arabia.
Al Khathaami AM; Al Bdah B; Tarawneh M; Alskaini M; Alotaibi F; Alshalan A; Almuhraj M; Aldaham D; Alotaibi N
J Stroke Cerebrovasc Dis; 2020 May; 29(5):104761. PubMed ID: 32173225
[TBL] [Abstract][Full Text] [Related]
16. Effects of Nursing Quality Improvement on Thrombolytic Therapy for Acute Ischemic Stroke.
Liu Z; Zhao Y; Liu D; Guo ZN; Jin H; Sun X; Yang Y; Sun H; Yan X
Front Neurol; 2018; 9():1025. PubMed ID: 30555408
[No Abstract] [Full Text] [Related]
17. Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke.
Zhai M; Cao S; Yang J; Cao X; Dong Z; Liu W; Fu Y; Guan Q; Wang Y; Liu H
Neurol Ther; 2023 Aug; 12(4):1105-1118. PubMed ID: 37166676
[TBL] [Abstract][Full Text] [Related]
18. Patients with Low National Institutes of Health Stroke Scale Scores Have Longer Door-to-Needle Times: Analysis of a Telestroke Network.
Bhatt A; Lesko A; Lucas L; Kansara A; Baraban E
J Stroke Cerebrovasc Dis; 2016 Sep; 25(9):2253-8. PubMed ID: 27266620
[TBL] [Abstract][Full Text] [Related]
19. Real-time feedback on mobile application use for emergency management affects the door-to-needle time and functional outcomes in acute ischemic stroke.
Reziya H; Sayifujiamali K; Han HJ; Wang XM; Nuerbiya T; Nuerdong D; Sang Q; Wu YF
J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107055. PubMed ID: 36801498
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a multicomponent intervention to shorten thrombolytic door-to-needle time in stroke patients in China (MISSION): A cluster-randomized controlled trial.
Zhong W; Lin L; Gong X; Chen Z; Chen Y; Yan S; Zhou Y; Zhang X; Hu H; Tong L; Cheng C; Gu Q; Chen Y; Yu X; Huang Y; Yuan C; Lou M;
PLoS Med; 2022 Jul; 19(7):e1004034. PubMed ID: 35788767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
